| abstract |
The proposed group of inventions relates to the field of medicine. A method and kit are proposed for determining the presence of cancer in a subject, including determining the concentration of Hsp90α in a plasma sample of the subject. The proposed use of EDTA-K2 as an anticoagulant in the plasma sample for the determination of Hsp90α. The proposed group of inventions provides an increase in the sensitivity and specificity of the diagnosis of cancer in a subject in the range of Hsp90α concentrations from 56 to 82 ng / ml. 3 n. and 8 hp f-ly, 15 ill., 51 tab., 8 Ave. |